HEADER TRANSFERASE/INHIBITOR 18-FEB-23 8G8O
TITLE THE CRYSTAL STRUCTURE OF JAK2 IN COMPLEX WITH COMPOUND 31
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2;
COMPND 5 EC: 2.7.10.2;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: JAK2;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS INHIBITOR, JAK2, KINASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR S.T.MILLER,D.A.ELLIS
REVDAT 5 13-NOV-24 8G8O 1 REMARK
REVDAT 4 15-NOV-23 8G8O 1 REMARK
REVDAT 3 25-OCT-23 8G8O 1 REMARK
REVDAT 2 26-JUL-23 8G8O 1 JRNL
REVDAT 1 21-JUN-23 8G8O 0
JRNL AUTH H.M.GORDHAN,S.T.MILLER,D.C.CLANCY,M.INA,A.V.MCDOUGAL,
JRNL AUTH 2 D.K.CUTNO,R.V.BROWN,C.L.LICHOROWIC,J.M.STURDIVANT,K.A.VICK,
JRNL AUTH 3 S.S.WILLIAMS,M.A.DELONG,J.C.WHITE,C.C.KOPCZYNSKI,D.A.ELLIS
JRNL TITL EYES ON TOPICAL OCULAR DISPOSITION: THE CONSIDERED DESIGN OF
JRNL TITL 2 A LEAD JANUS KINASE (JAK) INHIBITOR THAT UTILIZES A UNIQUE
JRNL TITL 3 AZETIDIN-3-AMINO BRIDGING SCAFFOLD TO ATTENUATE OFF-TARGET
JRNL TITL 4 KINASE ACTIVITY, WHILE DRIVING POTENCY AND AQUEOUS
JRNL TITL 5 SOLUBILITY.
JRNL REF J.MED.CHEM. V. 66 8929 2023
JRNL REFN ISSN 0022-2623
JRNL PMID 37314941
JRNL DOI 10.1021/ACS.JMEDCHEM.3C00519
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.18
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 30285
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.189
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.231
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1597
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2234
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.42
REMARK 3 BIN R VALUE (WORKING SET) : 0.1840
REMARK 3 BIN FREE R VALUE SET COUNT : 131
REMARK 3 BIN FREE R VALUE : 0.2870
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4625
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 64
REMARK 3 SOLVENT ATOMS : 110
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.11
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -5.99000
REMARK 3 B22 (A**2) : 13.81000
REMARK 3 B33 (A**2) : -7.82000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.33000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.058
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.044
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.220
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4793 ; 0.009 ; 0.013
REMARK 3 BOND LENGTHS OTHERS (A): 4554 ; 0.001 ; 0.017
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6464 ; 1.623 ; 1.657
REMARK 3 BOND ANGLES OTHERS (DEGREES): 10492 ; 1.240 ; 1.586
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 555 ; 6.642 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 270 ;34.062 ;22.259
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 877 ;17.403 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;21.861 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 593 ; 0.072 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5297 ; 0.007 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 1107 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2238 ; 3.975 ; 3.853
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2237 ; 3.972 ; 3.853
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2784 ; 5.656 ; 5.760
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2785 ; 5.656 ; 5.761
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2555 ; 4.153 ; 4.215
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2556 ; 4.153 ; 4.215
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3676 ; 6.032 ; 6.185
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 19854 ; 9.885 ;72.786
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 19837 ; 9.889 ;72.788
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NCS TYPE: LOCAL
REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1
REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT
REMARK 3 1 A B 9228 0.09 0.05
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 8G8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-FEB-23.
REMARK 100 THE DEPOSITION ID IS D_1000272349.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 27-JUN-21
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I03
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2
REMARK 200 DATA SCALING SOFTWARE : XDS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31923
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 47.180
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 6.500
REMARK 200 R MERGE (I) : 0.17500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 1.31900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3IOK
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 42.54
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM ACETATE, HEPES,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 89.78000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 815
REMARK 465 HIS A 816
REMARK 465 HIS A 817
REMARK 465 HIS A 818
REMARK 465 HIS A 819
REMARK 465 HIS A 820
REMARK 465 HIS A 821
REMARK 465 THR A 822
REMARK 465 SER A 823
REMARK 465 LEU A 824
REMARK 465 TYR A 825
REMARK 465 LYS A 826
REMARK 465 LYS A 827
REMARK 465 ALA A 828
REMARK 465 GLY A 829
REMARK 465 PHE A 830
REMARK 465 LEU A 831
REMARK 465 VAL A 832
REMARK 465 PRO A 833
REMARK 465 ARG A 834
REMARK 465 GLY A 835
REMARK 465 SER A 836
REMARK 465 GLU A 837
REMARK 465 ASP A 838
REMARK 465 ARG A 839
REMARK 465 ASP A 840
REMARK 465 PRO A 841
REMARK 465 HIS A 886
REMARK 465 SER A 887
REMARK 465 ALA A 920
REMARK 465 ASN A 1067
REMARK 465 ASP A 1068
REMARK 465 LYS A 1069
REMARK 465 GLN A 1070
REMARK 465 ALA A 1131
REMARK 465 GLY A 1132
REMARK 465 MET B 815
REMARK 465 HIS B 816
REMARK 465 HIS B 817
REMARK 465 HIS B 818
REMARK 465 HIS B 819
REMARK 465 HIS B 820
REMARK 465 HIS B 821
REMARK 465 THR B 822
REMARK 465 SER B 823
REMARK 465 LEU B 824
REMARK 465 TYR B 825
REMARK 465 LYS B 826
REMARK 465 LYS B 827
REMARK 465 ALA B 828
REMARK 465 GLY B 829
REMARK 465 PHE B 830
REMARK 465 LEU B 831
REMARK 465 VAL B 832
REMARK 465 PRO B 833
REMARK 465 ARG B 834
REMARK 465 GLY B 835
REMARK 465 SER B 836
REMARK 465 GLU B 837
REMARK 465 ASP B 838
REMARK 465 ARG B 839
REMARK 465 ASP B 840
REMARK 465 PRO B 841
REMARK 465 THR B 842
REMARK 465 ALA B 920
REMARK 465 GLY B 921
REMARK 465 GLU B 1012
REMARK 465 PRO B 1013
REMARK 465 GLY B 1014
REMARK 465 ASN B 1067
REMARK 465 ASP B 1068
REMARK 465 LYS B 1069
REMARK 465 GLN B 1070
REMARK 465 ALA B 1131
REMARK 465 GLY B 1132
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 922 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 923 CG CD NE CZ NH1 NH2
REMARK 470 LYS A1011 CG CD CE NZ
REMARK 470 GLN A1072 CG CD OE1 NE2
REMARK 470 ARG B 922 CG CD NE CZ NH1 NH2
REMARK 470 ARG B 923 CG CD NE CZ NH1 NH2
REMARK 470 LYS B1011 CG CD CE NZ
REMARK 470 GLN B1072 CG CD OE1 NE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 922 -45.08 -139.44
REMARK 500 ARG A 971 32.73 70.86
REMARK 500 ASP A 976 31.58 -140.71
REMARK 500 LYS A1011 74.65 -110.59
REMARK 500 SER B 887 59.27 -103.19
REMARK 500 ASP B 976 32.15 -143.85
REMARK 500 PRO B1017 78.32 -69.22
REMARK 500
REMARK 500 REMARK: NULL
DBREF 8G8O A 837 1132 UNP O60674 JAK2_HUMAN 837 1132
DBREF 8G8O B 837 1132 UNP O60674 JAK2_HUMAN 837 1132
SEQADV 8G8O MET A 815 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 816 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 817 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 818 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 819 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 820 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS A 821 UNP O60674 EXPRESSION TAG
SEQADV 8G8O THR A 822 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER A 823 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LEU A 824 UNP O60674 EXPRESSION TAG
SEQADV 8G8O TYR A 825 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LYS A 826 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LYS A 827 UNP O60674 EXPRESSION TAG
SEQADV 8G8O ALA A 828 UNP O60674 EXPRESSION TAG
SEQADV 8G8O GLY A 829 UNP O60674 EXPRESSION TAG
SEQADV 8G8O PHE A 830 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LEU A 831 UNP O60674 EXPRESSION TAG
SEQADV 8G8O VAL A 832 UNP O60674 EXPRESSION TAG
SEQADV 8G8O PRO A 833 UNP O60674 EXPRESSION TAG
SEQADV 8G8O ARG A 834 UNP O60674 EXPRESSION TAG
SEQADV 8G8O GLY A 835 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER A 836 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER A 1073 UNP O60674 MET 1073 ENGINEERED MUTATION
SEQADV 8G8O THR A 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION
SEQADV 8G8O MET B 815 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 816 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 817 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 818 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 819 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 820 UNP O60674 EXPRESSION TAG
SEQADV 8G8O HIS B 821 UNP O60674 EXPRESSION TAG
SEQADV 8G8O THR B 822 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER B 823 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LEU B 824 UNP O60674 EXPRESSION TAG
SEQADV 8G8O TYR B 825 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LYS B 826 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LYS B 827 UNP O60674 EXPRESSION TAG
SEQADV 8G8O ALA B 828 UNP O60674 EXPRESSION TAG
SEQADV 8G8O GLY B 829 UNP O60674 EXPRESSION TAG
SEQADV 8G8O PHE B 830 UNP O60674 EXPRESSION TAG
SEQADV 8G8O LEU B 831 UNP O60674 EXPRESSION TAG
SEQADV 8G8O VAL B 832 UNP O60674 EXPRESSION TAG
SEQADV 8G8O PRO B 833 UNP O60674 EXPRESSION TAG
SEQADV 8G8O ARG B 834 UNP O60674 EXPRESSION TAG
SEQADV 8G8O GLY B 835 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER B 836 UNP O60674 EXPRESSION TAG
SEQADV 8G8O SER B 1073 UNP O60674 MET 1073 ENGINEERED MUTATION
SEQADV 8G8O THR B 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION
SEQRES 1 A 318 MET HIS HIS HIS HIS HIS HIS THR SER LEU TYR LYS LYS
SEQRES 2 A 318 ALA GLY PHE LEU VAL PRO ARG GLY SER GLU ASP ARG ASP
SEQRES 3 A 318 PRO THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN
SEQRES 4 A 318 GLN LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS
SEQRES 5 A 318 ARG TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL
SEQRES 6 A 318 ALA VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU
SEQRES 7 A 318 ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU
SEQRES 8 A 318 GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR
SEQRES 9 A 318 SER ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR
SEQRES 10 A 318 LEU PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS
SEQRES 11 A 318 LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR
SEQRES 12 A 318 SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS
SEQRES 13 A 318 ARG TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU
SEQRES 14 A 318 VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY
SEQRES 15 A 318 LEU THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS
SEQRES 16 A 318 VAL LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA
SEQRES 17 A 318 PRO GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER
SEQRES 18 A 318 ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE
SEQRES 19 A 318 THR TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE
SEQRES 20 A 318 MET ARG MET ILE GLY ASN ASP LYS GLN GLY GLN SER ILE
SEQRES 21 A 318 VAL THR HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG
SEQRES 22 A 318 LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET
SEQRES 23 A 318 ILE MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG
SEQRES 24 A 318 PRO SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE
SEQRES 25 A 318 ARG ASP ASN MET ALA GLY
SEQRES 1 B 318 MET HIS HIS HIS HIS HIS HIS THR SER LEU TYR LYS LYS
SEQRES 2 B 318 ALA GLY PHE LEU VAL PRO ARG GLY SER GLU ASP ARG ASP
SEQRES 3 B 318 PRO THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN
SEQRES 4 B 318 GLN LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS
SEQRES 5 B 318 ARG TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL
SEQRES 6 B 318 ALA VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU
SEQRES 7 B 318 ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU
SEQRES 8 B 318 GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR
SEQRES 9 B 318 SER ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR
SEQRES 10 B 318 LEU PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS
SEQRES 11 B 318 LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR
SEQRES 12 B 318 SER GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS
SEQRES 13 B 318 ARG TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU
SEQRES 14 B 318 VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY
SEQRES 15 B 318 LEU THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS
SEQRES 16 B 318 VAL LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA
SEQRES 17 B 318 PRO GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER
SEQRES 18 B 318 ASP VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE
SEQRES 19 B 318 THR TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE
SEQRES 20 B 318 MET ARG MET ILE GLY ASN ASP LYS GLN GLY GLN SER ILE
SEQRES 21 B 318 VAL THR HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG
SEQRES 22 B 318 LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET
SEQRES 23 B 318 ILE MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG
SEQRES 24 B 318 PRO SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE
SEQRES 25 B 318 ARG ASP ASN MET ALA GLY
MODRES 8G8O PTR A 1007 TYR MODIFIED RESIDUE
MODRES 8G8O PTR A 1008 TYR MODIFIED RESIDUE
MODRES 8G8O PTR B 1007 TYR MODIFIED RESIDUE
MODRES 8G8O PTR B 1008 TYR MODIFIED RESIDUE
HET PTR A1007 16
HET PTR A1008 16
HET PTR B1007 16
HET PTR B1008 16
HET YT0 A1201 28
HET DMS A1202 4
HET YT0 B1201 28
HET EDO B1202 4
HETNAM PTR O-PHOSPHOTYROSINE
HETNAM YT0 [1-{5-METHYL-2-[(3-METHYL-1,2-THIAZOL-5-YL)
HETNAM 2 YT0 AMINO]PYRIMIDIN-4-YL}-3-(4-METHYLPIPERAZIN-1-YL)
HETNAM 3 YT0 AZETIDIN-3-YL]ACETONITRILE
HETNAM DMS DIMETHYL SULFOXIDE
HETNAM EDO 1,2-ETHANEDIOL
HETSYN PTR PHOSPHONOTYROSINE
HETSYN EDO ETHYLENE GLYCOL
FORMUL 1 PTR 4(C9 H12 N O6 P)
FORMUL 3 YT0 2(C19 H26 N8 S)
FORMUL 4 DMS C2 H6 O S
FORMUL 6 EDO C2 H6 O2
FORMUL 7 HOH *110(H2 O)
HELIX 1 AA1 GLU A 845 ARG A 847 5 3
HELIX 2 AA2 GLU A 889 SER A 904 1 16
HELIX 3 AA3 SER A 936 LYS A 945 1 10
HELIX 4 AA4 GLU A 946 ILE A 948 5 3
HELIX 5 AA5 ASP A 949 LYS A 970 1 22
HELIX 6 AA6 ALA A 978 ARG A 980 5 3
HELIX 7 AA7 PRO A 1017 TYR A 1021 5 5
HELIX 8 AA8 ALA A 1022 SER A 1029 1 8
HELIX 9 AA9 SER A 1032 THR A 1049 1 18
HELIX 10 AB1 GLU A 1052 LYS A 1055 5 4
HELIX 11 AB2 SER A 1056 GLY A 1066 1 11
HELIX 12 AB3 SER A 1073 ASN A 1084 1 12
HELIX 13 AB4 PRO A 1095 TRP A 1106 1 12
HELIX 14 AB5 ASN A 1109 ARG A 1113 5 5
HELIX 15 AB6 SER A 1115 ASN A 1129 1 15
HELIX 16 AB7 GLU B 845 ARG B 847 5 3
HELIX 17 AB8 THR B 888 LEU B 905 1 18
HELIX 18 AB9 SER B 936 LYS B 945 1 10
HELIX 19 AC1 GLU B 946 ILE B 948 5 3
HELIX 20 AC2 ASP B 949 LYS B 970 1 22
HELIX 21 AC3 ALA B 978 ARG B 980 5 3
HELIX 22 AC4 PRO B 1017 TYR B 1021 5 5
HELIX 23 AC5 ALA B 1022 SER B 1029 1 8
HELIX 24 AC6 SER B 1032 THR B 1049 1 18
HELIX 25 AC7 GLU B 1052 LYS B 1055 5 4
HELIX 26 AC8 SER B 1056 GLY B 1066 1 11
HELIX 27 AC9 SER B 1073 ASN B 1084 1 12
HELIX 28 AD1 PRO B 1095 TRP B 1106 1 12
HELIX 29 AD2 ASN B 1109 ARG B 1113 5 5
HELIX 30 AD3 SER B 1115 ASN B 1129 1 15
SHEET 1 AA1 5 LEU A 849 LYS A 857 0
SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853
SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866
SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880
SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928
SHEET 1 AA2 2 TYR A 972 ILE A 973 0
SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973
SHEET 1 AA3 2 ILE A 982 ASN A 986 0
SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983
SHEET 1 AA4 2 PTR A1008 LYS A1009 0
SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008
SHEET 1 AA5 5 LEU B 849 LYS B 857 0
SHEET 2 AA5 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853
SHEET 3 AA5 5 VAL B 878 LEU B 884 -1 O VAL B 879 N CYS B 866
SHEET 4 AA5 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880
SHEET 5 AA5 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928
SHEET 1 AA6 2 TYR B 972 ILE B 973 0
SHEET 2 AA6 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973
SHEET 1 AA7 2 ILE B 982 ASN B 986 0
SHEET 2 AA7 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983
SHEET 1 AA8 2 PTR B1008 LYS B1009 0
SHEET 2 AA8 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008
LINK C GLU A1006 N PTR A1007 1555 1555 1.34
LINK C PTR A1007 N PTR A1008 1555 1555 1.34
LINK C PTR A1008 N LYS A1009 1555 1555 1.34
LINK C GLU B1006 N PTR B1007 1555 1555 1.35
LINK C PTR B1007 N PTR B1008 1555 1555 1.34
LINK C PTR B1008 N LYS B1009 1555 1555 1.34
CRYST1 36.580 179.560 52.210 90.00 110.53 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.027337 0.000000 0.010237 0.00000
SCALE2 0.000000 0.005569 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020452 0.00000